A woman outdoors at sunset, looking up, concentric rings drawn around her

Our Services · Screening · Breast Health

Breast Health & Advanced Imaging

From AI-powered 3D screening mammography to breast MRI, ultrasound and image-guided biopsy — RadNet delivers expert breast care, including subspecialized breast radiologists, at imaging centers across the country.

+21.6%

Cancer detection

Powered by DeepHealth AI and Safeguard review.

2 million+

Mammograms annually

About 5% of the United States total.

Enhanced Breast Cancer Detection, powered by DeepHealth

The power of AI behind your screening mammogram

A screening mammogram as the radiologist sees it without EBCD, with no areas marked.

Without EBCD

The radiologist views the exam without assistance.

The same exam reviewed with EBCD. The AI has outlined three areas of interest, two labelled LO and one labelled HIGH.

With EBCD

Suspicious areas are highlighted for the radiologist.

How Enhanced Breast Cancer Detection works

AI applied to a mammogram 01

After your exam, Artificial Intelligence (AI) technology is applied to your mammogram.

AI marking areas of interest 02

On 3D mammograms, the AI marks areas of interest and how suspicious each looks, for the radiologist to review.

The AI output compared with the radiologist's assessment 03

After the radiologist reads your exam, the AI’s output is compared with their assessment.

A second radiologist reviewing the exam 04

Certain exams with suspicious findings are reviewed by a second radiologist for determination of final results.

published in Nature Health

The ASSURE study

The benefits of RadNet’s EBCD (Enhanced Breast Cancer Detection) workflow, which leverages AI and rigorous clinical review to strengthen the effectiveness of mammography, are validated by the largest real-world analysis of AI-enabled breast cancer screening in the U.S. as of November 2025.

21.6%

Increase in cancer detection

The cancer detection rate rose from 4.6 to 5.6 per 1,000 screens after the AI workflow was added at 109 community imaging centers, compared with standard 3D mammography reading before it.

579K+

Mammograms evaluated

The ASSURE study evaluated more than 579,000 mammograms, making it the most comprehensive U.S. analysis of AI-enabled breast cancer screening as of November 2025.

22.7%

Higher detection in women with dense breasts

AI-enabled screening improved detection in dense-breast patients, addressing one of the most challenging limitations of mammography.

15%

Higher positive predictive value (PPV1)

Radiologists identified more true cancers per recall.

Equitable

Outcomes across patient populations

Study scale enabled statistical analyses by subpopulation, which revealed equitable performance across racial and ethnic groups, with no disparities widened.

Acceptable

No disproportionate increase in recalls

Recall rates rose modestly (10.6% to 11.1%) and stayed within ACR guidelines while detection and PPV1 improved.

Source: Louis LD, et al. Nature Health 1, 58–66 (2026). Increases are relative to standard 3D mammography reading before the AI workflow.

Through EBCD, RadNet has screened 1.5M+ women and helped detect 1,000+ additional cancers (as of November 2025).

Mammo Dx™ Artificial Intelligence, powered by DeepHealth. Mammo Dx is for 3D (tomosynthesis) screening mammograms only, not diagnostic mammograms. It is an adjunct tool, not intended to replace a radiologist’s own review of a mammogram — the final interpretation is made by a radiologist. Mammography does not detect all breast cancer lesions, and even with Mammo Dx some lesions may not be identified.

What we offer

Comprehensive breast imaging

Breast imaging covers a range of advanced procedures radiologists use to detect and diagnose breast cancer. Mammography is where breast care starts — these are the exams we use alongside it, and who each one is for.

Screening & diagnostic

Mammography

An X-ray of the breast, and the exam most patients come to us for. It is used two ways — as a routine annual screen for women with no symptoms, and as a more detailed diagnostic study when there is something specific to look at.

  • Screening mammography A routine X-ray of the breast used to detect breast cancer in women who have no signs or symptoms. It is a preventative measure, recommended annually from age 40 — or earlier for women considered high risk.
  • Diagnostic mammography Performed when there are signs or symptoms of a potential breast issue — a lump, breast pain, nipple discharge, or a change found on a screening mammogram. It provides more detailed images to evaluate the area of concern closely and guide whether further testing is needed.
  • 3D mammography (tomosynthesis) Images taken from several angles build a three-dimensional view of the breast, each scan taking about four seconds, so radiologists can examine the tissue layer by layer and pick up subtle abnormalities — particularly valuable for women with dense breast tissue. Software on our units removes the need for the extra images the exam once required, which keeps the dose low.
  • What it feels like The breast is positioned and briefly compressed while each image is taken — usually two views of each breast. The compression is firm and lasts only a few seconds, and the whole exam runs 15–20 minutes.
Supplemental · high risk

Breast MRI

  • What it is Powerful magnets and radio waves build very clear pictures of soft tissue — no radiation, and no compression of the breast. For the exams used to detect or evaluate cancer, contrast is given through an IV.
  • Why it helps It finds small lesions that mammography sometimes misses.
  • Who it is for Some women, because of family history, a genetic tendency or other risk factors, should be screened with MRI in addition to mammograms. Talk with your doctor about whether you should have additional tests.
Supplemental · dense breasts

Breast ultrasound

  • What it is Sound waves instead of X-rays. A transducer is passed over the breast and the returning sound is translated into a picture on a monitor. It is generally painless, and with no radiation it carries very little risk.
  • Why it helps It tells a fluid-filled cyst apart from a solid mass, and it reaches lesions close to the chest wall where mammography is less useful.
  • Who it is for Women with dense breasts, and anyone whose mammogram or physical exam turned up something that needs a closer look.
Supplemental · dense breasts or intermediate risk

Contrast-enhanced mammography (CEM)

  • What it is A mammogram with contrast. You are given an IV, then a special mammogram captures two images within a second of each other — the ordinary picture, and one showing where the contrast has gone.
  • Why it helps The contrast highlights areas of increased blood flow, which can make some cancers easier to see. It brings much of the sensitivity of MRI to a mammography platform.
  • Who it is for Used as supplemental imaging for some women with dense breasts, and for those at intermediate risk.

Your physician decides which exam answers the question they are asking. Availability varies by center — ask us when you schedule.

Interventional procedures

Image-guided biopsies

When an abnormality requires tissue sampling, RadNet provides outpatient, minimally invasive image-guided biopsies. Procedures are performed under local anesthesia with no hospital stay.

Biopsy typeGuidancePrimary indicationTechnique
Stereotactic / 3D DBT biopsy 3D digital mammography coordinates Non-palpable microcalcifications or architectural distortions seen only on mammogram Core needle samples target tissue through a tiny skin nick.
Ultrasound-guided biopsy Real-time high-resolution ultrasound Palpable lumps or solid masses visible on sonogram Core needle retrieved under direct continuous visual tracking.
MRI-guided breast biopsy High-field MRI guidance grid Lesions visible strictly via breast MRI contrast enhancement Core needle sampling performed inside a specialized grid localization.
High-risk management & genetics

Care for patients at elevated risk

At select West Coast locations, when family history, a prior finding or a risk model points to elevated risk, RadNet coordinates what comes next — assessment, genetic testing and navigation — through our Breastlink breast care teams.

Integrated risk assessment

Screening patients are offered a no-cost high-risk questionnaire using the Tyrer-Cuzick model.


36-gene genetic testing panel

In partnership with Ambry Genetics and Cedars-Sinai Cancer, patients whose risk assessment meets NCCN criteria for genetic testing are offered comprehensive genetic screening for inherited cancer mutations.


Dedicated patient navigators

Individualized clinical guidance to coordinate diagnostic follow-up, surgical consultations and oncology referrals without delay.


Breastlink centers, where available

In California and Arizona, our Breastlink centers bring breast imaging, surgery and medical oncology together in a single practice. Visit Breastlink

Alternative points of care

Screening where you already are

In select markets, RadNet meets women where they live, work and shop to break down historical barriers to screening access.

Pure Mammography

Mammogram and ultrasound centers inside Roosevelt Field and Smith Haven malls on Long Island.

Available in New York.

Visit Pure Mammography

MammogramNow at Super Walmart

Retail screening centers inside Super Walmart locations, reaching underserved populations and first-time screeners.

Available in California and Delaware.

Visit MammogramNow

Mobile mammography coaches

Mobile 3D mammography units servicing corporate campuses, rural communities and health fairs, with EBCD available at additional cost.

Available in select markets.

About mobile mammography
Common questions

Breast imaging questions

The American College of Radiology recommends women aged 40 and older should have a screening mammogram every year and should continue to do so for as long as they are in good health.

No physician referral is required for screening mammography, but you must have an established healthcare provider who can receive and review your results.

EBCD pairs the radiologist with FDA-cleared AI and a built-in second review. After your exam, the AI marks areas of interest on your 3D mammogram and how suspicious each looks, then, after the radiologist reads the exam, the AI’s output is compared with their assessment — and where the radiologist reads the exam as normal but the AI flags high suspicion, a second breast specialist reviews it. Your mammogram experience remains the same: no additional radiation or time is required.

Yes — and it has been validated at scale. The ASSURE study, published in Nature Health, evaluated RadNet’s EBCD workflow across more than 579,000 mammograms, the largest real-world analysis of AI-enabled breast cancer screening in the U.S. as of November 2025. In that before-and-after comparison, the AI-augmented workflow had a 21.6% higher cancer detection rate (5.6 versus 4.6 per 1,000 screens) than standard 3D mammography reading.

Density is common, and it is not a diagnosis. In the ASSURE study, AI-enabled screening improved detection in dense-breast patients by 22.7% — addressing one of the most challenging limitations of mammography. Discuss what density means for your own screening with your physician.

Breast MRI is typically recommended for women with a lifetime risk of breast cancer of 20% or higher, including BRCA1/BRCA2 carriers and some women with a personal or strong family history, and for checking silicone breast implants.

Image-guided breast biopsies are outpatient, minimally invasive procedures performed under local anesthesia, with no hospital stay. The guidance method — 3D mammography, ultrasound or MRI — is matched to how the finding is best seen.

Yes. Please provide access to any mammograms performed at other facilities for vital year-over-year comparison. Without them your results may be delayed, or you may be asked to return for additional imaging.

Next step

Schedule your mammogram

No physician referral is required for screening mammography, but you must have an established healthcare provider who can receive and review your results.

Loading locations...

Getting availability

Patient portals by region